SCHEMBL5116891

SCHEMBL5116891

Nc1ccc2c(c1)CC(=O)N2CCF

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 0.50
BRD4 O60885 1/20 0.37
HTR7 P34969 9/20 0.37
PER2 O15055 1/20 0.36
CRY2 Q49AN0 1/20 0.36
BMPR1B O00238 2/20 0.36
BMPR1A P36894 2/20 0.36
TGFBR1 P36897 2/20 0.36
ACVRL1 P37023 2/20 0.36
ACVR1 Q04771 2/20 0.36
GAA P10253 2/20 0.35
CASP1 P29466 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR1A P08908 5/20 0.35
ALDH1A1 P00352 1/20 0.35
DRD2 P14416 1/20 0.35
DRD5 P21918 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26621670 0.84 ATAD2 (0.50) ATAD2BRD4HTR7BMPR1BBMPR1A
SCHEMBL31419471 0.84 ATAD2 (0.50) ATAD2BRD4HTR7BMPR1BBMPR1A
SCHEMBL5116351 0.84 ATAD2 (0.57) ATAD2BRD4HTR7BMPR1BBMPR1A
SCHEMBL5505351 0.83 ATAD2 (0.56) ATAD2BRD4HTR7BMPR1BBMPR1A
SCHEMBL30661654 0.81 ATAD2 (0.48) ATAD2BRD4HTR7BMPR1BBMPR1A
SCHEMBL26621476 0.81 ATAD2 (0.45) ATAD2BRD4HTR7BMPR1BBMPR1A
SCHEMBL26621598 0.81 ATAD2 (0.48) ATAD2BRD4HTR7BMPR1BBMPR1A
SCHEMBL30661535 0.81 ATAD2 (0.74) ATAD2BRD4BMPR1BBMPR1ATGFBR1
SCHEMBL4105161 0.81 ATAD2 (0.74) ATAD2BRD4BMPR1BBMPR1ATGFBR1
SCHEMBL8510313 0.81 ATAD2 (0.50) ATAD2BRD4HTR7BMPR1BBMPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080262056-A1 Oxindole Oxazolidinones as Antibacterial Agents PFIZER INC 2008-10-23 US disclosed
US-20060229348-A1 Oxindole oxazolidinone as antibacterial agent JOSYULA VARA PRASAD V N 2006-10-12 US disclosed
US-20060030609-A1 Oxazolidinones containing oxindoles as antibacterial agents LUEHR GARY W 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229348-A1 Oxindole oxazolidinone as antibacterial agent OXA1L, MRPL21, RPS27L ATAD2 1754/4885BRD4 1152/4885HTR7 2877/4885
US-20080262056-A1 Oxindole Oxazolidinones as Antibacterial Agents OXA1L, OXSR1, OXER1 ATAD2 1891/4885BRD4 1581/4885HTR7 1651/4885
US-20060030609-A1 Oxazolidinones containing oxindoles as antibacterial agents OXA1L, OXSR1, OXER1 ATAD2 1520/4885BRD4 1128/4885HTR7 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.